LOG IN
SIGN UP
MARKET
LUMO
LUMO
Lumos Pharma Inc
NASDAQ
5.02
+0.03
+0.52%
Opening 15:51 11/29 EST
OPEN
4.850
PREV CLOSE
4.990
HIGH
5.13
LOW
4.850
VOLUME
6.68K
TURNOVER
28.37K
52 WEEK HIGH
10.27
52 WEEK LOW
4.465
MARKET CAP
42.01M
P/E (TTM)
-1.4744
1D
5D
1M
3M
1Y
5Y
4D Molecular, Azenta top healthcare gainers; Twist Bioscience, Lumos among losers
Seekingalpha · 11/15 15:00
Jefferies Downgrades Lumos Pharma to Hold, Announces $7 Price Target
Benzinga · 11/15 13:35
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Benzinga · 11/15 10:19
--Jefferies Downgrades Lumos Pharma to Hold From Buy With $7 Price Target
--Jefferies Downgrades Lumos Pharma to Hold From Buy With $7 Price Target
MT Newswires · 11/15 09:36
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Benzinga · 11/14 18:05
MMAT, PRCH and CABA among mid-day movers
Seekingalpha · 11/14 17:51
Lumos Pharma Says Growth Hormone Deficiency Trial Meet Expectations
Benzinga · 11/14 17:29
Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday
Benzinga · 11/14 15:57
About LUMO
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, acquiring, developing, and commercializing products and therapies for people with rare diseases. Its lead product candidate is LUM-201, a therapy for pediatric growth hormone deficiency (PGHD) and other rare endocrine disorders. LUM-201 stimulates growth hormone (GH) through the GH secretagogue receptor. Its product provides a differentiated mechanism of action to treat rare endocrine disorders by increasing the amplitude of endogenous and pulsatile GH secretion. LUM-201 is an orally administered small molecule, which is a GH secretagogue for rare endocrine disorders where injectable recombinant human growth hormone (rhGH) is approved. Its pipeline features development programs for rare diseases associated with growth hormone deficiencies. Its subsidiaries include NewLink International, BlueLink Pharmaceuticals, Inc, BioProtection Systems Corporation and Lumos Pharma Sub, Inc.
Webull offers kinds of Lumos Pharma Inc stock information, including NASDAQ:LUMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUMO stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading LUMO stock methods without spending real money on the virtual paper trading platform.